Bone-protecting effect of safflower seeds in ovariectomized rats

Calcified Tissue International

Volumn 71, Issue 1, 2002, Pages 88-94

  Kim, H J ^a   Bae, Y C ^b   Park, R W ^a   Choi, S W ^c   Cho, S H ^c   Choi, Y S ^d   Lee, W J ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Daegu University   (South Korea)

Author keywords

Bone protection; Osteoblast proliferation; Osteoporosis; Phytoestrogen; Polyphenolic compounds

Indexed keywords

ESTRADIOL; GENISTEIN; PHYTOESTROGEN; POLYPHENOL DERIVATIVE; SAFFLOWER OIL; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MASS; CELL PROLIFERATION; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG MECHANISM; ESTROGEN DEFICIENCY; FEMALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; PLANT SEED; PRIORITY JOURNAL; RAT; SAFFLOWER; SCANNING ELECTRON MICROSCOPY; SUNFLOWER; TIBIA; TRABECULAR BONE; UTERUS; ANIMAL; ANIMAL FOOD; DRUG EFFECT; HISTOLOGY; ORGAN SIZE; PATHOLOGY; PHYTOTHERAPY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMAL FEED; ANIMALS; BODY WEIGHT; CARTHAMUS TINCTORIUS; DIET; FEMALE; MICROSCOPY, ELECTRON, SCANNING; ORGAN SIZE; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; TIBIA; UTERUS;

EID: 0036653633     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-1080-4     Document Type: Article

References (43)

1. Genant HK, Baylink DJ, Gallagher JC (1989) Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161:1842-1846
2. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C (1999) Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10:253-260
3. Knight DC, Eden JA (1996) A review of the clinical effects of phytoestrogens. Obstet Gynecol 87:897-904
4. Anderson JB, Garner SC (1997) The effects of phytoestrogens on bone. Nutr Res 17:1617-1632
5. Tham DM, Gardner CD, Haskell WL (1998) Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. Eur J Clin Nutr 52:850-855
6. Kurzer M, Xu X (1997) Dietary phytoestrogens. Annu Rev Nutr 17:353-381
7. Brzezinski A, Debi A (1999) Phytoestrogens: the natural selective estrogen receptor modulators? Eur J Ob/Gy Reprod Biol 85:47-51
8. Setchell KDR, Adlercreutz H (1988) Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism and biological role in health and disease. In: The role of gut microflora in toxicity and cancer. Academic Press, New York, pp 315-345
9. Miksicek RJ (1994) Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49:153-160
10. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Prince RL (1997) Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 127:1795-1799
11. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852
12. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68 (suppl):1375S-1379S
13. Tsuchida K, Mizushima S, Toba M, Soda K (1999) Dietary soybeans intake and bone mineral density among 995 middle-aged women in Yokohama. J Epidemiol 9: 14-19
14. Arjmandi BH, Alekel L, Hollis BW (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167
15. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC (1998) Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian deficiency in rats. Am J Clin Nutr 68(suppl):1358S-1363S
16. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC (1998) Bone-protecting effect of soy protein in ovarian hormone-deficient rat is related to isoflavone content. Am J Clin Nutr 68(suppl):1364S-1368S
17. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporosis Int 8:274-281
18. Ishimi Y, Arai N, Wang X, Wu J, Umegaki K, Miyaura C, Takeda A, Ikegami S (2000) Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem Biophys Res Com 274:697-701
19. Huh J, (1989) Herbe. Dongeui Bogam, Vol 3, Yeogang Publisher, Seoul Korea, p 2763
20. Kang GH, Chang EJ, Choi SW (1999) Antioxidative activity of phenolic compounds in roasted safflower (Carthamus tinctorius L.) seeds. J Food Sci Nutr 4:221-225
21. Kim JH, Jeon SM, An MY, Koo SK, Lee JH, Moon KD, Choi MS (1998) The effects of Korean safflower (Carthamus tinctorius L.) seed powdered diet on bone tissue in rats during the recovery of rib fracture. Korean Soc Food Sci Nutr 27:1-7
22. Yamaura M, Nakamura T, Kanou A, Miura T, Ohara H, Suzuki K (1994) The effect of 17 beta-estradiol treatment on the mass and the turnover of bone in ovariectomized rats taking a mild dose of thyroxin. Bone Miner 24:33-42
23. Bagi CM, Miller SC (1994) Comparison of osteopenic changes in cancellous bone induced by ovariectomy and/or immobilization in adult rats. Anat Rec 239:243-254
24. Rodan GA, Rodan SG (1984) Expression of the osteoblastic phenotype. In: WA Peck (ed) Advances in bone and mineral research, annual II. Excerpta Medica, Amsterdam, pp 244-285
25. Robinson JA, Harris SA, Riggs BL, Spelsberg TC (1997) Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138:2919-2927
26. Sugimoto E, Yamaguchi M (2000) Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5:515-520
27. Kalu DN (1991) The ovariectomized rat model of post-menopausal bone loss. Bone Miner 15:175-191
28. Frost HM, Jee WSS (1992) On the rat model of human osteopenias and osteoporosis. Bone Miner 18:227-236
29. Seo HJ, Kim JH, Kwak DY, Jeon SM, Ku SK, Lee JH, Moon KD, Choi MS (2000) The effects of safflower seed powder and its fraction on bone tissue in rib-fractured rats during the recovery. Korean J Nutr 33:411-420
30. Kalu DN, Masoro EJ, Byung PY, Hardin RR, Hollis BW (1988) Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology 122:1847-1854
31. Valente M, Bufalino L, Castiglione ON, Castiglione GN, D'Angelo R, Mancuso A, Galoppi P, Zichella L (1994) Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 54:377-380
32. Thompson LU, Seidl MM, Rickard S, Orcheson L, Fong HHS (1996) Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26:159-165
33. Prasad K (1997) Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol Cell Biochem 168:117-123
34. Ward WE, Yuan YV, Cheung AM, Thompson LU (2000) Exposure to lignan enhances femur biomechanism strength in young but not older female rats. J Bone Miner Res 15(suppl 1):S238
35. Ward WE, Yuan YV, Cheung AM, Thompson LU (2001) Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats. J Toxicol Environ Health 63:53-65
36. Tsutsumi N (1995) Effect of coumestrol on bone metabolism in organ culture. Biol Pharm Bull 18:1012-1015
37. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Prince RL (1997) Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 127:1795-1799
38. Kim JH (1998) The effects of Korean safflower (Carthamus tinctorius L.) seed powder-supplemented diet on the recovery of rib fracture and lipid metabolism in rats, and development of processed food. Ph.D thesis, Kyungpook National University, Daegu, Korea
39. Martin RB, Chow BD, Lucas PA (1990) Bone marrow fat content in relation to bone re-modeling and serum chemistry in intact and ovariectomized dogs. Calcif Tissue Int 46:189-194
40. Wronski TJ, Walsh CC, Ignaszewskin LA (1986) Histologic evidence for osteopenia and increased bone turn over in ovariectomized rats. Bone 7:119-123
41. Nuttall ME, Gimble JM (2000) Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184
42. Nuttall ME, Patton AJ, Oliverta DL, Nadeau PD, Gowen ME (1998) Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 13:371-382
43. Zava DT, Duwe G (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27(1):31-40